Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hyundai Motor (005380) – Decision on Cash and In-Kind Dividend / 2024-01-25 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Provisional Operating Results Based on Consolidated Financial Statements (Fair Disclosure) / 2024-10-23 Disclosures
  • [Disclosure] Samsung Biologics (207940) – (Correction) Investor Caution Notice on Stock Futures and Options / 2025-08-22 Disclosures
  • [Disclosure] SK Square (402340) – Matters Related to Obligatory Fair Disclosure / 2024-03-28 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Provisional Sales Results (Fair Disclosure) / 2024-11-01 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Clarification of Rumors or Reports (Unconfirmed) / 2026-04-06 Disclosures
  • [Disclosure] Hana Micron (067310) – Results of Annual General Meeting of Shareholders / 2025-03-28 Semiconductors
  • [Disclosure] Jusung Engineering (036930) – Consolidated Financial Results (Provisional) / 2025-07-30 Semiconductors

[Disclosure] Celltrion (068270) – Decision on Acquisition of Treasury Shares / 2025-05-20

Posted on May 20, 2025August 6, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Celltrion has decided to acquire 649,351 common treasury shares (approx. KRW 100.0B) through open market purchases to stabilize share prices and enhance shareholder value, with plans to cancel all acquired shares.

📊 [Key Disclosure Details & Financial Summary]

  • Disclosure Title: Decision on Acquisition of Treasury Shares
  • Number of Shares to be Acquired: 649,351 common shares
  • Estimated Total Acquisition Amount: KRW 100,000,054,000 (approx. KRW 100.0B / based on the closing price of KRW 154,000 prior to the board decision)
  • Scheduled Acquisition Period: May 21, 2025 ~ August 20, 2025
  • Purpose of Acquisition: Share price stabilization and enhancement of shareholder value
  • Method of Acquisition: On-market purchase via KOSPI
  • Entrusted Brokerage Firms: NH Investment & Securities Co., Ltd., Meritz Securities Co., Ltd.
  • Daily Purchase Order Limit: 122,542 common shares
  • Post-Acquisition Plan: All acquired shares are planned for cancellation
  • Treasury Share Holdings Prior to Acquisition:
    • Acquired within dividend availability: 5,420,368 common shares (2.4%)
    • Other acquisitions: 5,004,847 common shares (2.2%)
    • Total Treasury Shares: 10,425,215 common shares
  • Board Resolution Date: May 20, 2025 (8 outside directors present)
  • Statutory Dividend-Available Capital Limit for Buybacks: KRW 4,482,476,707,586 (approx. KRW 4.48T)

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Open-Market Buyback Execution and Subsequent Share Cancellation

This disclosure details Celltrion’s decision to buy back approx. KRW 100.0B worth of common shares and subsequently cancel them to enhance shareholder value. It is key to monitor the actual execution of open-market purchases during the scheduled period (May 21, 2025 ~ August 20, 2025) and subsequent share cancellation filings. Tracking buyback progress and retirement confirms the implementation of shareholder return policies. Final acquisition results and cancellation updates can be verified through the post-completion ‘Report on Results of Treasury Share Acquisition’, subsequent ‘Decision on Cancellation of Treasury Shares’ disclosures, or upcoming periodic filings (Quarterly, Half-Yearly, or Annual Business Reports).

📢 Disclaimer & Source Information

Source: This content was newly generated and structured based on official data submitted to the Data Analysis, Retrieval and Transfer System (DART) of the Financial Supervisory Service.

Investment Risk Notice: This information is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Hanmi Semiconductor (042700) – Decision on Stock Retirement / 2025-05-19
Next Post: [Disclosure] Samsung Biologics (207940) – Request for Inquiry Disclosure Regarding Rumors or Press Reports / 2025-05-21

Related Posts

  • [Disclosure] Samsung Electronics (005930) – Investor Relations (IR) Announcement / 2026-04-07 Semiconductors
  • [Disclosure] SK Hynix (000660 / SKHY) – Setting of Shareholder Register Closure Period or Record Date / 2024-09-12 Semiconductors
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Holding / 2026-05-11 Semiconductors
  • [Disclosure] Wonik IPS (240810) – Change of Chief Executive Officer (CEO) / 2024-01-02 Semiconductors
  • [Disclosure] SK hynix (000660 / SKHY) – Results of General Shareholders’ Meeting / 2024-03-27 Disclosures
  • [Disclosure] HPSP (403870) – Corporate Value-up Plan / 2026-04-30 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Supply Contract / 2025-06-26 Disclosures
  • [Disclosure] KEPCO (015760 / KEP) – (Correction) Decision on Debt Guarantee for Others / 2024-11-28 Energy
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset Securities | Expanded HBM/eSSD Share · Earnings Upgrades · Target Price Raised / 2025-01-24 RESEARCH
  • [Disclosure] PSK Holdings (031980) – Submission of Audit Report / 2026-03-20 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – Yuanta Securities | AI Server Demand · Memory Leadership · Target Price Upgrade / 2024-10-25 RESEARCH
  • [Disclosure] Celltrion (068270) – Decision on Closure of Shareholders’ Register (Record Date) for Cash/In-Kind Dividend / 2024-12-13 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05 Disclosures
  • [Disclosure] Samsung Electronics(005930) – Resolution on Convening of General Shareholders’ Meeting / 2024-02-20 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme